These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15120608)

  • 41. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
    Shishodia S; Amin HM; Lai R; Aggarwal BB
    Biochem Pharmacol; 2005 Sep; 70(5):700-13. PubMed ID: 16023083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
    Qiao Q; Jiang Y; Li G
    Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
    Bharti AC; Donato N; Singh S; Aggarwal BB
    Blood; 2003 Feb; 101(3):1053-62. PubMed ID: 12393461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Small interfering RNA-mediated nuclear factor-kappaB P65 suppression induces apoptosis of hepatic carcinoma SMMC-7721 cells].
    Huang C; Yao JY; Li ZF; Liu LY; Ni L; Song TS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1841-4. PubMed ID: 18158998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity.
    Nakaya A; Sagawa M; Muto A; Uchida H; Ikeda Y; Kizaki M
    Leuk Res; 2011 Feb; 35(2):243-9. PubMed ID: 20542334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB.
    Nourbakhsh M; Hauser H
    EMBO J; 1999 Nov; 18(22):6415-25. PubMed ID: 10562553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
    Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A functional NF-kappaB binding site in the human papillomavirus type 16 long control region.
    Fontaine V; van der Meijden E; de Graaf J; ter Schegget J; Struyk L
    Virology; 2000 Jun; 272(1):40-9. PubMed ID: 10873747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway].
    Tian F; Song M; Xu PR; Liu HT; Xue LX
    Ai Zheng; 2008 Jun; 27(6):566-70. PubMed ID: 18570726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL; Wu JG; Dai N; Yu HG; Si JM
    Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
    Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
    Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
    Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
    Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice.
    Huang S; DeGuzman A; Bucana CD; Fidler IJ
    Clin Cancer Res; 2000 Jun; 6(6):2573-81. PubMed ID: 10873114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventricular myocytes.
    Kirshenbaum LA
    Clin Invest Med; 2000 Oct; 23(5):322-30. PubMed ID: 11055326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.
    Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
    Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
    Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB.
    Huang G; Yang Y; Xu Z; Zhou P; Gong W; Li Y; Fan J; He F
    Eur J Pharmacol; 2011 Jan; 650(1):451-7. PubMed ID: 20950605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with the proto-oncogene c-Myc.
    Chapman NR; Webster GA; Gillespie PJ; Wilson BJ; Crouch DH; Perkins ND
    Biochem J; 2002 Sep; 366(Pt 2):459-69. PubMed ID: 12027803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
    Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
    J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.